Douglas A. Grimm
About Douglas A. Grimm
Douglas A. Grimm is a Partner and Health Care Practice Leader known for his insights on pharmaceutical regulations, hospital mergers, telehealth practices, and legal challenges in the health care industry.
Title
Douglas A. Grimm holds the position of Partner and Health Care Practice Leader. In his role, he drives initiatives that shape the future of health care practices within the firm.
Pharmaceutical Manufacturers and 340B Drug Discounts
Douglas A. Grimm has been quoted on the topic of pharmaceutical manufacturers easing restrictions on 340B drug discounts. This comes as a response to more states making attempts to widen the accessibility of the program’s benefits. His insights reflect his deep understanding of industry regulations and their impacts on state-level health care.
Federal Trade Commission and Hospital Mergers
Douglas A. Grimm provided commentary on the Federal Trade Commission’s rejected attempt to block a proposed merger between two hospitals in North Carolina. His perspective offers a nuanced understanding of regulatory actions and their implications for hospital consolidation.
Telehealth Best Practices and Compliance
Douglas A. Grimm discusses telehealth best practices, emphasizing HIPAA compliance and patient education. His contributions highlight the evolving landscape of telehealth and the importance of maintaining regulatory standards while educating patients.
Top Legal Challenges in Health Care for 2024
Douglas A. Grimm participated in a discussion centered on identifying 10 legal challenges facing the health care industry in 2024. His expertise provides a forward-looking view of potential legal hurdles and regulatory changes that may affect health care practices and policies.